Rocket Pharmaceuticals Inc (RCKT)
11.78
-0.77
(-6.14%)
USD |
NASDAQ |
Jan 08, 16:00
11.78
0.00 (0.00%)
After-Hours: 17:12
Rocket Pharmaceuticals Shareholders Equity (Quarterly): 329.77M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 508.40M |
| Inogen Inc | 185.40M |
| Marinus Pharmaceuticals Inc | -66.74M |
| Spyre Therapeutics Inc | 327.39M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 393.69M |
| Total Liabilities (Quarterly) | 63.92M |